Clinical Trial Update: Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours [Phase 1]

View source ↗

Summary

Phase 1 safety study of CHR-2797 in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CHR-2797 (CHR-2797)

Snippet

Sponsor: Chroma Therapeutics | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED